Victory Capital Management Inc Bei Gene, Ltd. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$146.52 - $269.56 $962,343 - $1.77 Million	-6,568 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$248.56 - $389.34 $1.63 Million - $2.56 Million	6,568 New	6,568 $1.78 Million
Q3 2021 Nov 02, 2021	SELL	$249.6 - $403.14 $1.61 Million - $2.61 Million	-6,463 Closed	0 $0
Q2 2021 Aug 03, 2021	SELL	$292.75 - $367.01 $16,686 - $20,919	-57 Reduced 0.87%	6,463 $2.22 Million
Q1 2021 May 04, 2021	BUY	$260.64 - $382.12 $246,044 - $360,721	944 Added 16.93%	6,520 $2.27 Million
Q4 2020 Feb 01, 2021	SELL	$221.31 - $316.61 $1.36 Million - $1.95 Million	-6,154 Reduced 52.46%	5,576 $1.44 Million
Q3 2020 Nov 09, 2020	SELL	$189.18 - $286.44 $75,672 - $114,576	-400 Reduced 3.3%	11,730 $3.36 Million
Q2 2020 Aug 07, 2020	SELL	$123.9 - $195.41 $3.41 Million - $5.38 Million	-27,513 Reduced 69.4%	12,130 $2.29 Million
Q1 2020 May 04, 2020	SELL	$121.84 - $173.19 $184,343 - $262,036	-1,513 Reduced 3.68%	39,643 $4.88 Million
Q4 2019 Feb 06, 2020	BUY	$115.78 - $208.34 $33,576 - $60,418	290 Added 0.71%	41,156 $6.82 Million
Q4 2019 Feb 04, 2020	SELL	$115.78 - $208.34 $6.05 Million - $10.9 Million	-52,282 Reduced 56.13%	40,866 $6.23 Million
Q3 2019 Nov 12, 2019	BUY	$120.61 - $148.29 $6.59 Million - $8.1 Million	54,598 Added 141.63%	93,148 $11.4 Million
Q2 2019 Aug 15, 2019	SELL	$113.99 - $146.86 $24 Million - $30.9 Million	-210,680 Reduced 84.53%	38,550 $4.78 Million
Q1 2019 May 03, 2019	BUY	$122.82 - $151.83 $2.99 Million - $3.7 Million	24,350 Added 10.83%	249,230 $32.9 Million
Q4 2018 Feb 05, 2019	BUY	$107.01 - $175.15 $7.16 Million - $11.7 Million	66,950 Added 42.39%	224,880 $31.5 Million
Q3 2018 Nov 01, 2018	SELL	$152.62 - $189.66 $105,307 - $130,865	-690 Reduced 0.44%	157,930 $27.2 Million
Q2 2018 Aug 02, 2018	BUY	$152.5 - $216.77 $24.2 Million - $34.4 Million	158,620 New	158,620 $24.4 Million

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$1.89 Billion
25.41% of portfolio
Capital International Investors Los Angeles, CA

6.43M
Shares

$1.15 Billion
0.29% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$927 Million
26.65% of portfolio
Primecap Management CO Pasadena, CA

4.97M
Shares

$891 Million
0.84% of portfolio
Baillie Gifford & CO

3.71M
Shares

$664 Million
0.64% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.6B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account